Skip to main content
Clinical Trials/ITMCTR2200005975
ITMCTR2200005975
Not yet recruiting
Phase 1

Based on gut microbiota-gut-brain axis to explore the clinical of electroacupuncture in the treatment of post-stroke cognitive impairment

The First Affiliated Hospital of Henan University of Chinese Medicine0 sitesTBD
Conditionsstroke

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
stroke
Sponsor
The First Affiliated Hospital of Henan University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of Henan University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • ?China guidelines for the diagnosis and treatment of acute ischemic stroke 2018 and China guidelines for the prevention and treatment of cerebrovascular diseases;?were confirmed to have a history of ischemic stroke by CT or MRI;?were determined the degree of cognitive impairment after assessing by mini\-mental state examination (MMSE) and Montreal Cognitive Assessment (MoCA) which occurred after ischemic stroke;?are already ill more than or equal to one month and less than or equal to one year; ?never use drugs improving cognitive function were used before enrollment;?are conscious and have stable vital signs.

Exclusion Criteria

  • ?Participants suffered from other diseases that could lead to cognitive impairment, such as intracranial space occupying lesions, brain trauma, aneurysms, etc;?Patients with other diseases will lead to the failure of cognitive impairment examination, such as abnormal audio\-visual function, mental disorder and so on;?The patient had cognitive impairment or had been diagnosed with dementia before this onset;?The patient has other serious diseases, such as immune diseases, endocrine diseases and abnormal liver and kidney function;?Women is pregnant or breastfeeding;?The patient has coagulation dysfunction.

Outcomes

Primary Outcomes

Not specified

Similar Trials